What Dosage of Semaglutide Should I Take? Your Guide to Personalized Weight Loss

Last reviewed: June 9, 2026

Last updated: June 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide has shown consistent weight loss results in clinical trials, with participants losing an average of 10–15% of body weight within 68 weeks. However, the dose that works best for you depends on your individual physiology, not just a standard protocol. Finding your right semaglutide dosage requires thoughtful evaluation of your baseline health, tolerance, and metabolic response.

How Semaglutide Dosage Works for Weight Loss

Semaglutide is a GLP-1 receptor agonist that signals your brain to reduce appetite and regulate blood sugar. Unlike some medications where higher doses mean faster results, semaglutide requires a gradual titration schedule—starting low and increasing over weeks—to minimize side effects and allow your body to adapt. Most treatment plans begin with the lowest effective dose and escalate only when your body tolerates the current level well.

The standard starting point for semaglutide weight loss therapy is typically 0.25 mg weekly, increased in 0.25 mg increments every four weeks until reaching a maintenance dose. However, this timeline and these numbers represent general guidance, not a fixed requirement. Your healthcare provider may adjust this schedule based on your response, tolerance, and goals.

Why Personalized Dosing Matters More Than Standard Protocols

Your genetics, current medications, kidney and liver function, and previous medication experiences all influence how your body processes semaglutide. Two patients starting at the same dose may report completely different outcomes—one experiences rapid appetite suppression and modest nausea, while the other feels minimal effect. This variance reflects real biological differences in how your GLP-1 receptors respond to the medication.

PlexusDx takes a precision approach by evaluating your medical history, current health markers, and optional genetic insights before recommending a starting dose and titration plan. This personalization reduces the trial-and-error phase, helping you reach an effective dose faster while minimizing unwanted side effects.

The Role of Genetics in Your Semaglutide Response

The PlexusDx Precision Peptide Genetic Test analyzes MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

PlexusDx offers the Precision Peptide Genetic Test for $298. This test maps 14 metabolic pathways, 49 peptide markers, and 150+ genetic insights, including variants in GIPR and FTO, and MC4R genes. Understanding your genetic predispositions helps your provider anticipate your likely response pattern and tailor your dosage trajectory to match your biology, not just population averages.

Finding Your Optimal Semaglutide Dose Without Guesswork

Your optimal dose is the amount that produces meaningful appetite reduction and steady weight loss while keeping side effects tolerable for your lifestyle. Some patients feel satisfied at 0.5 mg weekly, while others need 1.0 mg or higher. The goal is never to reach the highest possible dose—it's to find the lowest dose that delivers the results you want with a side effect profile you can sustain.

PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan), with your dose able to increase as needed over time. The pricing remains flat regardless of how your dose evolves—your dose may go up, but your price won't. During your initial consultation, PlexusDx providers assess your weight loss targets, current medications, medical conditions, and tolerance threshold to recommend a starting point tailored to you. Weekly check-ins during your first month allow rapid adjustments if you experience unexpected reactions or insufficient appetite suppression.

Common Questions About Semaglutide Dosing and Adjustment

Many patients wonder how quickly they can increase their dose or whether skipping a dose is safe. Dose escalation is intentionally gradual because it allows your gastrointestinal system, appetite center, and metabolic hormones time to rebalance. Jumping doses or increasing too rapidly often triggers nausea, vomiting, or constipation severe enough to interrupt treatment. Your provider may slow your titration if you report significant side effects or accelerate it slightly if you show excellent tolerance.

If you miss a dose, take it as soon as possible unless your next scheduled injection is within two days. Consistency matters more than perfection—missing one or two doses over months won't derail your progress, but returning to a regular schedule quickly prevents appetite rebound and keeps you on track toward your weight loss goal.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Precision Peptide Genetic Test is $298. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is a typical starting dose of semaglutide for weight loss?

Most weight loss protocols begin semaglutide at 0.25 mg injected subcutaneously once weekly, increased by 0.25 mg increments every four weeks based on tolerance and response. PlexusDx providers personalize this schedule during your first consultation, potentially adjusting both the starting amount and escalation timeline to fit your individual physiology and tolerance.

How long does it take to reach a maintenance dose?

The standard 16-week titration schedule escalates from 0.25 mg to a typical maintenance of 1.0 mg. However, some patients reach their optimal dose in 8–12 weeks, while others benefit from a slower 20-week schedule to minimize side effects. PlexusDx adjusts your timeline based on your response pattern and goals.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

Yes. Variants in GIPR, MC4R, and FTO genes measurably influence appetite signaling and metabolic response to GLP-1 therapy. The PlexusDx Precision Peptide Genetic Test ($298) identifies your genetic predispositions across 49 peptide markers, helping your provider anticipate your likely dose response and adjust your plan proactively rather than reactively.

What if I experience side effects at my current dose?

Nausea, constipation, and appetite loss are common during titration and often improve within days to weeks as your body acclimates. If side effects are severe or persistent, your PlexusDx provider may pause your dose increase, lower your current dose temporarily, or add supportive strategies like dietary adjustments. Stopping treatment is rarely necessary.

Does PlexusDx charge more for higher doses?

No. PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan)—a flat rate that does not increase as your dose increases. Whether you inject 0.25 mg or 2.0 mg weekly, your monthly cost stays the same. This pricing model removes the financial barrier to finding your truly optimal dose.

Is compounded semaglutide as safe as the brand name version?

PlexusDx sources all semaglutide from licensed 503A compounding pharmacies, which are regulated by state pharmacy boards and the FDA. Compounded semaglutide has the same active ingredient and mechanism as brand Ozempic and Wegovy but is customizable to your specific needs and typically more affordable. Always inform your provider of all medications to catch potential interactions.

Related Reading

• Semaglutide For Weight Loss 2
• Glp 1 Dosage For Weight Loss
• Semaglutide Tablets For Weight Loss
• Semaglutide Pills For Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.